Subramanian K. Vadivel

The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition

María Scherma, Julie Medalie, Walter Fratta et al. · Neuropharmacology · 2007 · 150 citations · Full text

Medicine, Neuroscience, Pharmacology +9

The Endogenous Cannabinoid Anandamide Produces δ-9-Tetrahydrocannabinol-Like Discriminative and Neurochemical Effects That Are Enhanced by Inhibition of Fatty Acid Amide Hydrolase but Not by Inhibition of Anandamide Transport

Marcello Solinas, Gianluigi Tanda, Zuzana Justinová et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 103 citations · Full text

Medicine, Neuroscience, Pharmacology +10

The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine‐induced dopamine elevations in the nucleus accumbens shell in rats

María Scherma, Zuzana Justinová, Claudio Zanettini et al. · British Journal of Pharmacology · 2011 · 69 citations · Full text

Medicine, Neuroscience, Pharmacology +15

Endocannabinoid and Cannabinoid-Like Fatty Acid Amide Levels Correlate with Pain-Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study

Jakub Fichna, JodiAnne T. Wood, Malvina Papanastasiou et al. · PLoS ONE · 2013 · 61 citations · Full text

Medicine, Clinical Sciences, Pharmacology +17

Equipotent Inhibition of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase – Dual Targets of the Endocannabinoid System to Protect against Seizure Pathology

Vinogran Naidoo, David A. Karanian, Subramanian K. Vadivel et al. · Neurotherapeutics · 2012 · 59 citations · Full text

Medicine, Neuroscience, Pharmacology +17